Marchi, Saverio http://orcid.org/0000-0003-2708-1843
Guilbaud, Emma http://orcid.org/0000-0001-5261-1944
Tait, Stephen W. G. http://orcid.org/0000-0001-7697-132X
Yamazaki, Takahiro
Galluzzi, Lorenzo http://orcid.org/0000-0003-2257-8500
Article History
Accepted: 28 June 2022
First Online: 25 July 2022
Competing interests
: L.G. has held research contracts with Lytix Biopharma and Promontory, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Sotio, Promontory, Noxopharm, EduCom and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. All other authors declare no conflicts of interest.
Free to read: This content has been made available to all.